Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A07E INTESTINAL ANTIINFLAMMATORY AGENTS
A07EC Aminosalicylic acid and similar agents
A07EC04 Balsalazide
D02715 Balsalazide disodium (USP) <US>
USP drug classification [BR:br08302]
Inflammatory Bowel Disease Agents
Aminosalicylates and/or Prodrugs
Balsalazide
D02715 Balsalazide disodium (USP)
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01909 Anti-inflammatory drug, salicylic acid derivatives
DG00100 Balsalazide
D02715 Balsalazide disodium
Drug classes [BR:br08332]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
D02715 Balsalazide disodium
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02715
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02715
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01909 Anti-inflammatory drug, salicylic acid derivatives
DG00100 Balsalazide